David Agus, co-founder of Navigenics and author of 'The End of Illness,' argues that without theory, medicine can't move forward.
Dr. David B. Agus
David Agus is one of the world’s top cancer doctors and a pioneer in new technologies for personalized health care. A professor at USC, with appointments in both the Keck School of Medicine and the Viterbi School of Engineering, he also heads the university’s Westside Cancer Center and the Center for Applied Molecular Medicine. He has cofounded several businesses, including the genetic testing company Navigenics and Oncology.com. He is also a cofounder of Applied Proteomics, which aims to tap the tremendous wealth of information contained in the body’s proteome—the complete set of all proteins circulating in the bloodstream—for earlier diagnosis of disease. Agus is a CBS News contributor and author of the number one New York Times best seller The End of Illness. His new book, A Short Guide to a Long Life, will be published in January 2014.